Skip to content
Open Data Finder
data.gov.au

COVID-19 Vaccine Multi-omics Dataset: Pfizer, Moderna and AstraZeneca

Published by CSIRO Data Access Portal

About this dataset

This collection contains the data supporting the study “Multi-omics integration reveals vaccine-specific molecular signatures and temporal dynamics of COVID-19 immune responses.” The study profiled plasma samples from SARS-CoV-2–naïve adults vaccinated with Pfizer-BioNTech, Moderna, or AstraZeneca COVID-19 vaccines using proteomic, lipidomic, and metabolomic approaches. Samples were analysed at baseline and two weeks after the second vaccine dose, with additional longitudinal timepoints available for the Pfizer-BioNTech cohort at six months after the second dose and two weeks after the third dose. The collection includes the processed multi-omics datasets and associated information used for differential abundance, longitudinal, and integrated multi-omics analyses reported in the publication.

COVID-19 Vaccine Multi-omics Dataset: Pfizer, Moderna and AstraZeneca · Open Data Finder